Atsuro Nakazato - Concepedia

Author

Atsuro Nakazato

Taisho Pharmaceutical (Japan)

Also Known As

Atsuro Nakazato

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Taisho Pharmaceutical (Japan)Nihon Nohyaku (Japan)The University of Osaka RIKEN Center for Computational Science

About

Atsuro Nakazato is an author at Taisho Pharmaceutical (Japan) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	33	1.8K
2	Social Sciences	15	16	834
3	Biochemistry	8	8	355
4	Natural Sciences	6	6	262
5	Engineering	2	2	37

Atsuro Nakazato

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity Shigeyuki Chaki, Ryoko Yoshikawa, Shiho Hirota, Neuropharmacology Antidepressant-like ActivityPsychoactive DrugPsychiatryFunctional SelectivityMedicine	2003	250
Design, synthesis and structure–affinity relationships of aryloxyanilide derivatives as novel peripheral benzodiazepine receptor ligands Taketoshi Okubo, Ryoko Yoshikawa, Shigeyuki Chaki, Bioorganic & Medicinal Chemistry Molecular PharmacologyPharmaceutical ChemistryDerivativesMedicineAryloxyanilide Derivatives	2003	156
Receptor Binding, Behavioral, and Electrophysiological Profiles of Nonpeptide Corticotropin-Releasing Factor Subtype 1 Receptor Antagonists CRA1000 and CRA1001 Shigeru Okuyama, Shigeyuki Chaki, Naoya Kawashima, Journal of Pharmacology and Experimental Therapeutics	1999	153
Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450 Shigeyuki Chaki, Atsuro Nakazato, Ludo Kennis, European Journal of Pharmacology Molecular PharmacologyAntidepressant-like ProfilePsychiatryMedicinePsychotropic Medication	2003	123
NE-100, a novel sigma receptor ligand: In vivo tests Shigeru Okuyama, Yasuko Imagawa, Shinichi Ogawa, Life Sciences Autoimmune DiseaseNovel TherapyMedicineImmunologyTherapeutic Efficacy	1993	120
Anxiolytic-Like and Antidepressant-Like Activities of MCL0129 (1-[(S)-2-(4-Fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a Novel and Potent Nonpeptide Antagonist of the Melanocortin-4 Receptor Shigeyuki Chaki, Shiho Hirota, Takeo Funakoshi, Journal of Pharmacology and Experimental Therapeutics	2003	116
Synthesis, SARs, and Pharmacological Characterization of 2-Amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Derivatives as Potent, Selective, and Orally Active Group II Metabotropic Glutamate Receptor Agonists Atsuro Nakazato, Toshihito Kumagai, Kazunari Sakagami, Journal of Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryPharmacological CharacterizationBiochemistryCompound 4	2000	114
Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice Yukio Ago, Koji Yano, Ryota Araki, Neuropharmacology Stress HormonePsychiatryBehavioral NeurosciencePsychotropic MedicationBehavioural Pharmacology	2012	92
Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106 Shigeru Okuyama, Shigeyuki Chaki, Ryoko Yoshikawa, Life Sciences Molecular PharmacologyNeuropharmacological ProfileNeurophysiologyMedicinePsychotropic Medication	1999	90
Binding characteristics of DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors Shigeyuki Chaki, Takeo Funakoshi, Ryoko Yoshikawa, European Journal of Pharmacology Drug TargetBiochemistryFunctional SelectivityPeripheral Benzodiazepine ReceptorsMedicine	1999	80

Page 1